Your browser doesn't support javascript.
loading
CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade.
Morita, Tomoko Yamamori; Yu, Jie; Kashima, Yukie; Kamata, Ryo; Yamamoto, Gaku; Minamide, Tatsunori; Mashima, Chiaki; Yoshiya, Miyuki; Sakae, Yuta; Yamauchi, Toyohiro; Hakozaki, Yumi; Kageyama, Shun-Ichiro; Nakamura, Akito; Lightcap, Eric; Tanaka, Kosuke; Niu, Huifeng; Kannan, Karuppiah; Ohashi, Akihiro.
  • Morita TY; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Yu J; Oncology Drug Discovery Unit, Takeda Development Center Americas (TDCA), Inc., Lexington, MA, USA.
  • Kashima Y; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Kamata R; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Yamamoto G; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Minamide T; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Mashima C; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Yoshiya M; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan.
  • Sakae Y; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Yamauchi T; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Hakozaki Y; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Kageyama SI; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Nakamura A; Department of Integrated Bioscience, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Lightcap E; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Tanaka K; Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Niu H; Oncology Drug Discovery Unit, Takeda Development Center Americas (TDCA), Inc., Lexington, MA, USA.
  • Kannan K; Oncology Drug Discovery Unit, Takeda Development Center Americas (TDCA), Inc., Lexington, MA, USA.
  • Ohashi A; Division of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
Nat Commun ; 14(1): 7490, 2023 11 18.
Article en En | MEDLINE | ID: mdl-37980406
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Ciclo Celular / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Ciclo Celular / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article